期刊文献+

血小板活化因子乙酰水解酶基因Val379Ala位点多态性与脓毒症易感性相关性研究

Correlation between gene polymorphism of platelet - activating factor acetylhydrolase and susceptibility of sepsis
暂未订购
导出
摘要 目的探讨血小板活化因子乙酰水解酶(PAF-AH)基因Val379Ala位点多态性与脓毒症易感性及预后的关系。方法采用PCR-RFLP技术,分析82例不同程度脓毒症患者及90名健康对照者PAF-AH基因Val379Ala位点的多态性,对含有等位基因多态性的片段进行DNA测序分析。结果全部样本经PCR-RFLP分析后,脓毒症组82例中,仅1例纯合子Val/Val型,24例杂合子Val/Ala型,57例纯合子Ala/Ala型;对照组90例中,2例Val/Val型,29例Val/Ala型,59例Ala/Ala型。Val379Ala基因型和等位基因频率:脓毒症组与对照组比较差异无统计学意义(P〉0.05),存活组、死亡组与对照组比较差异无统计学意义(P〉0.05),轻型脓毒症组、严重脓毒症组与对照组比较差异无统计学意义(P〉0.05)。结论PAF-AH基因Val379Ala位点多态性与脓毒症易感性、预后及病情严重程度可能不相关。 Objective To discuss the allele frequency and genotypic distribution of platelet - activating factor acetylhydrolase (PAF-AH) gene polymorphism in the patients with sepsis. Methods Val379Ala site genotypes were determined in the patients(n=82)and healthy controls(n=90) by means of restriction fragment length polymorphism analysis of polymerase chain reaction products, DNA sequencing was used to detect the PCR product containing allele gene polymorphism. SPSS 13.0 statistical software was used to analyze. Results All the samples by PCR - RFLP analysis of the PAF-AH gene in the Val379Ala site had three kinds of genotypes : in 82 cases of sepsis group, there were 1 homo- zygous Val/Val type, 24 heterozygous Val/Ala type, 57 homozygous Ala/Ala type; in 90 cases of control group, there were 2 Val/Val type, 29 Val/Ala type, 59 Ala/Ala type. The Va1379Ala allele frequency and genotypic distribution in the patients with sepsis was not significantly different from those in the healthy controls(P〉 0.05) ; no statistically significant difference was observed among the survival group , the death group and the control group (P〉0.05) ; no statistically significant difference was ob- served among the mild sepsis group, severe sepsis group and control group (P〉0.05). Conclusion No correlations were found between PAF-AH gene Val379Ala polymorphism and sepsis.
出处 《中国急救医学》 CAS CSCD 北大核心 2009年第11期999-1002,共4页 Chinese Journal of Critical Care Medicine
关键词 脓毒症 血小板活化因子乙酰水解酶 基因多态性 Sepsis Platelet - activating factor acetylhydrolase Gene polymorphism
  • 相关文献

参考文献11

  • 1Graham RM, Stephens C J, Silvester W, et al. Plasma degradation of platelet - activating factor in severely ill patients with clinical sepsis[ J]. Crit Care Med, 1994,22(2) :204 -212.
  • 2Stafforini DM, Satoh K, Atkinson DL, et al. Platelet - activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti - inflammatory phospholipase[ J]. J Clin Invest,1996,97(12) : 2784 -2791.
  • 3Kruse S, Mao XQ, Heinzmann A, et al. The Ile198Thr and Ala379Val variants of plasmatic pal - acetylhydrolase impair catalytical activities and are associated with atop and asthma [J]. Am J Hum Genet,2000,66(5) :1522 -1530.
  • 4Levy MM, Fink MP, Marshall JC, et al. 2001SCCM/ESICM/ACCP/ATS/SIS International Sepsis Conference[ J]. Crit Care Med,2003,31 (4) :1250-1256.
  • 5Mathiak G, Szewczyk D, Abdullah F, et al. Platelet - activating factor (PAF) in experimental and clinical sepsis[J]. Shock,1997,7:391 -404.
  • 6Claus RA, Russwurm S, Dohrn B, et al. Plasma platelet - activating factor acetylhydrolase activity in critically ill patients [ J]. Crit Care Med, 2005,33 (6) :1416- 1419.
  • 7Gomes RN, Bozza FA, Amancio RT,et al. Exogenous platelet - activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis[ J ]. Shock, 2006,26 (1) :41 -49.
  • 8Arai H, Koizumi H, Aoki J, et al. Platelet - activating factor acetylhydrolase (PAF-AH) [J]. J Biochem, 2002,131 (5) :635 -640.
  • 9Liu PY, Hsing - Chun Chung, et al. Platelet - activating factor - acetylhydrolase( PLA2G7 ) A379V ( Exon 11 ) gene polymorphism is functionally associated with coronary artery disease severity but not the onset of acute coronary syndrome [ J ]. Acta Cardiol Sin, 2006,22 : 212 - 220.
  • 10李海林,程飞,黄永坤.血小板活化因子乙酰水解酶基因多态性与支气管哮喘的相关性[J].实用儿科临床杂志,2006,21(20):1396-1397. 被引量:1

二级参考文献11

  • 1朱进军.辅舒酮和万托林联合吸入治疗儿童哮喘的临床观察[J].现代医药卫生,2006,22(8):1144-1145. 被引量:1
  • 2王艳丽,刘君炎,王莹,陈和斌.哮喘患儿血清IL-4、TNF-α与IgE水平的探讨[J].华中医学杂志,2006,30(2):118-119. 被引量:5
  • 3朱玲,徐学鹏,余传星,林俊锦,何小丽.rhPLD2可降低豚鼠慢性哮喘模型血液中PAF的含量[J].中国免疫学杂志,2006,22(4):360-363. 被引量:2
  • 4Ishii S,Naqase T,Shindou H,et al.Platelet-activating factor receptor develops airway hyperresponsiveness independently of airway inflammation in a murine asthma model[J].J Immunol,2004,172(11):7095-7102.
  • 5Stafforini DM,Numao T,Tsodikov A,et al.Deficiency of platelet -activating factor acetylhydrolase is a severity factor for asthma[J].J Clin Invest,1999,103 (7):989-997.
  • 6Ito S,Noguchi E,Shibasaki M,et al.Evidence for an association between plasma platelet-activating factor acetylhydrolase deficiency and increased risk of childhood atopic asthma[J].J Hum Genet,2002,47(2):99-101.
  • 7Satoh N,Asano K,Naoli K,et al.Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma[J].Am J Respir Crit Care Med,1999,159(3):974-979.
  • 8Kruse S,Mso XQ,Heinzmann A,et al.The Ile198Thr and Ala379Val variants of plasmatic paf-acetylhydrolase impair catalytical activaties and are associated with atop and asthma[J].Am J Hum Genet,2000,66(5):1522-1530.
  • 9Stafforini DM,Satoh K,Atkinson DL,et al.Platelet-activating factor acetylhydrolsse deficiency.A missense mutation near the active site of an anti-inflammatory phospholipase[J].J Clin Invest,1996,97(12):2784-2791.
  • 10王振华,赵凯姝,鲁继荣,孙明远.哮喘患儿血小板活化因子乙酰水解酶活性的研究[J].实用儿科临床杂志,2004,19(2):120-121. 被引量:5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部